Melanoma differentiation associated gene-7 (mda-7): A novel anti-tumor gene for cancer gene therapy

Molecular Medicine

Volumn 7, Issue 4, 2001, Pages 271-282

  Mhashilkar, Abner M ^a   Schrock, Robert D ^a   Hindi, Mustafa ^a   Liao, Jennifer ^a   Sieger, Kerry ^a   Kourouma, Famourou ^a   Helena Zou Yang, X ^a   Onishi, Eric ^a   Takh, Oksana ^a   Vedvick, Thomas S ^b   Fanger, Gary ^b   Stewart, Lorna ^c   Watson, Graham J ^c   Snary, David ^c   Fisher, Paul B ^d   Saeki, Tomoyuki ^e   Roth, Jack A ^e   Ramesh, Rajagopal ^e   Chada, Sunil ^a  

^a Introgen Therapeutics Inc   (United States)

^b GLAXOSMITHKLINE   (United States)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d The New York Presbyterian Hospital   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLORING AGENT; GROWTH PROMOTOR; INTERLEUKIN 24; INTERLEUKIN DERIVATIVE; INTERLEUKIN-24; LIPOCORTIN 5; OXAZINE DERIVATIVE; PROPIDIUM IODIDE; RESAZURIN; THYMIDINE; TRYPAN BLUE; XANTHENE DERIVATIVE;

ADENOVIRUS; ARTICLE; CELL CULTURE; CELL DIVISION; CELL LINE; CELL SEPARATION; CHROMOSOME 1; CHROMOSOME MAP; CONFOCAL MICROSCOPY; DOSE RESPONSE; DRUG EFFECT; EXON; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE THERAPY; GENETIC TRANSDUCTION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; NEOPLASM; NICK END LABELING; TIME; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ADENOVIRIDAE; ANNEXIN A5; BLOTTING, WESTERN; CELL DIVISION; CELL LINE; CELL SEPARATION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; COLORING AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXONS; FLOW CYTOMETRY; GENE THERAPY; GENES, TUMOR SUPPRESSOR; GROWTH SUBSTANCES; HUMANS; IN SITU NICK-END LABELING; INTERLEUKINS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; NEOPLASMS; OXAZINES; PROPIDIUM; THYMIDINE; TIME FACTORS; TRANSDUCTION, GENETIC; TRYPAN BLUE; TUMOR CELLS, CULTURED; XANTHENES;

EID: 0035317682     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401847     Document Type: Article

References (41)

1. Kozarsky K, Wilson J. (1993) Gene therapy. Adenovirus vectors. Curr. Opin Gene Dev. 3: 499-503.
2. Swisher S, Roth J, Nemunaitis, Lawrence D, Kemp B, Carrasco C, Connors D, El-Naggar A, Fossella F, Glisson B, Hong W, Khuri F, Kurie J, Lee J, Lee J, Mack M, Merritt J, Nguyen D, Nesbitt J, Perez-Soler R, Pisters K, Putnam J Jr, Richli W, Savin M, Waugh M. (1999) Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J. Natl. Cancer Inst. 91: 763-771.
3. White E. (1996). Life, death and the pursuit of apoptosis. Genes Development 10: 1-15.
4. Jiang H, Fisher P. (1993) Use of a sensitive and efficient subtraction hybridization protocol for the identification of genes differentially expressed during growth, differentiation in human melanoma cells. Mol. Cell Different. 1: 285-299.
5. Jiang H, Lin J, Su Z, Goldstein N, Fisher P. (1995) Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene. 11: 2477-2486.
6. Jiang H, Su Z, Lin J, Goldstein N, Fisher, P. (1996) The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proc. Natl. Acad. Sci. 93: 9160-9165.
7. Su Z, Madireddi M, Lin J, Young C, Kitada S, Reed J, Goldstein N, Fisher P. (1998) The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proc Natl. Acad. Sci. 95: 14400-14405.
8. Su Z, Madireddi M, Young C, Jiang H, Goldstein N, Fisher P. (2000) Melanoma differentiation associated gene-7 (Mda-7): a ubiquitous cancer growth suppressor gene. Cancer Gene Therapy (in press).
9. Madireddi M, Su Z, Young C, Goldstein N, Fisher P. (2000) Mda-7, a novel melanoma differentiation associated gene with promise for cancer gene therapy. Cancer Gene Therapy: Past Achievements and Future Challenges (in press).
10. Madireddi M, Su Z, Young C, Goldstein N, Fisher P. (2000) Mda-7, a novel melanoma differentiation associated gene with promise for cancer gene therapy. Adv. Exp. Med. Biol. 465: 239-61.
11. Nielsen L, Maneval D. (1998) p53 tumor suppressor gene therapy for cancer. Cancer Gene Therapy. 5: 52-63.
12. Casey G, Lo-Hsueh M, Lopez M, Vogelstein B, Stanbridge E. (1991) Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene. Oncogene. 6: 1761-1797.
13. Graham F, Prevec. (1992) Adenovirus-based expression vectors and recombinant vaccines. Biotechnology. 20: 363-390.
14. Jiang H, Lin J, Su Z, Collart F, Huberman E, Fisher P. (1994) Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene. 9: 3397-3406.
15. Jiang H, Lin J, Su Z, Kerbel R, Herlyn M, Weissman D, Welch D, Fisher P. (1995) The melanoma differentiation associated gene MDA-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene. 10: 1855-1864.
16. Schneider C, King R, Philipson L. (1988) Genes specifically expressed at growth arrest of mammalian cells. Cell 54: 787-793.
17. Fornace A Jr, Alamo I Jr. Hollander M. (1988) DNA damage-inducible transcripts in mammalian cells. Proc. Natl. Acad. Sci. 85: 8800-8804.
18. Abdollahi A, Lord K, Hoffman-Liebermann B, Liebermann D. (1991) Sequence and expression of cDNA encoding MyD118: a novel myeloid differentiation primary response gene induced by multiple cytokines Oncogene. 6: 165-167.
19. Mooslehner K, Muller U, Karls U, Hamann L, Harbers K. (1991) Structure and expression of a gene encoding a putative GTP-binding protein identified by provirus integration in a transgenic mouse strain. Mol. Cell Biol. 11: 886-893.
20. Del Sal G, Murphy M, Ruaro E, Lazarevic D, Levine A, Schneider C. (1995) Cyclin Dl and p21/waf1 are both involved in p53 growth suppression. Oncogene. 12: 177-185.
21. Wu G, El-Diery W. (1996) p53 and chemosensitivity. Nat. Med. 2: 255-256.
22. Claudio P, Howard C, Baldi A, De Luca A, Fu Y, Condorelli G, Sun Y, Colburn N, Calabretta B, Giordano A. (1994) p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res. 54: 5556-5565.
23. Noda M, Kitayama H, Matsuzaki T, Sugimoto Y, Okayama H, Bassin R, Ikawa Y. (1988) Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes. Proc Natl. Acad. Sci. 86: 162-166.
24. Kitayama H, Sugimoto Y, Masuzaki T, Ikawa Y, Noda M. (1989) A ras-related gene with transformation suppressor activity. Cell 56: 77-84.
25. Reed J, Zha J, Aime-Sempe C, Takayama S, Wang, H. (1996) Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death. Adv. Exp. Med. Biol. 406: 99-112.
26. Soo C, Shaw W, Freymiller E, Longaker M, Bertolami C, Chie R, Tieu A, Ting K. (1999) Cutaneous rat wounds express c49a, a novel gene with homology to the human melanoma differentiation associated gene, MDA-7. J. Cell. Biochem. 74: 1-10.
27. Zhang R, Tan Z, Liang P. (2000) Identification of a novel lig-and-receptor pair constitutively activated by ras oncogenes. J. Biol. Chem. 11: 24436-24443.
28. Reed J. (1997) Double identity for proteins of the Bcl-2 family. Nature 387: 773-776.
29. Sedlak T, Oltvai Z, Yang E, Wang K, Boise L, Thompson C, Korysmeyer S. (1995) Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. 92: 7834-7838.
30. Umekita Y, Hiipakka R, Liao S. (1997) Rat and human maspins: structures, metastatic suppressor activity and mutation in prostate cancer cells. Cancer Letter 126: 87-93.
31. Mukherjee A, Kundu G. Mantile-Selvaggi G, Yuan C, Mandal A, Chattopadhyay S, Zheng F, Pattabiraman N, Zhang Z. (1999) Uteroglobin: a novel cytokine? Cell Mol. Life Sci. 55: 771-87.
32. Vajkoczy P, Menger M, Goldbrunner R, Ge S, Fong T, Vollmar B, Schilling L, Ullrich A, Hirth K, Tonn J, Schmiedek P, Rempel S. (2000) Int. J. Cancer. 87: 261-268.
33. Melkonyan H, Chang W, Shapiro J, Mahadevappa M, Fitzpatrick P, Kiefer M, Tomei L, Umansky S. (1997) SARPs: a family of secreted apoptosis-related proteins. Proc. Natl. Acad. Sci. 94: 13636-13641.
34. Saeki T, Mhashilkar A, Roth J, Chada S, Ramesh R. (2000) Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro. Gene Ther. 7: 2051-2057.
35. Bieche I, Champeme M, Lidereau R. (1995) Loss and gain of distinct regions of chromosome 1q in primary breast cancer. Clin. Cancer Res. 1: 123-127.
36. Gronwald J, Storkel S, Holtgreve-Grez H, Hadaczek P, Brinkschmidt C, Jauch A, Lubinski J, Cremer T. (1997) Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events. Cancer Res. 57: 481-487.
37. Petersen I, Bujard M, Petersen S, Wolf G, Goeze A, Schwendel A, Langreck H, Gellert K, Riechel M, Just K, Du Manoir S, Cremer T, Dietel M, Ried T. (1997) Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res. 57: (12): 2331-2335.
38. Sukamoto K, Yoshimoto M, Kasumi M, Akiyama F, Sakamoto G, Nakamura Y, Emi M. (1999) Frequent multiplication of chromosome 1q in non-invasive and papillotubular carcinoma of the breast. Cancer Letter. 141: 21-27.
39. Gallagher G, Dickensheets H, Eskdale J, Izotova L, Mirochnitchenko O, Peat J, Vazquez N, Pestka S, Donnelly R, Kotenko S. (2000) Cloning, expression and initial characterization of interleukin 19 (IL-19), a novel hoomologue of human IL-10 (IL-10). Genes and Immunity 1: 442-450.
40. Dumoutier L, Louahed J, Renauld J. (2000) Cloning and characterization of IL- 10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J. Immunol. 164: 1814-9.
41. Knappe A, Hor S, Wittmann S, Fickenscher H. (2000) Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri. J. Virol. 74: 3881-3887.